Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B

Natalia Martin Orozco, Noah Vale, Alan Mihic, Talya Amor, Lawrence Reiter, Yuko Arita, Reuben Samson, Queenie Hu, Anne-Claude Gingras, Brad Sorenson, Eric G. Marcusson, Piyush Patel
doi: https://doi.org/10.1101/2022.05.06.22274690

Data Availability

All data produced in the present work are contained in the manuscript.The development of the B.1.617.2 (Delta) lentiviral assay was supported by the CIHR operating grant to the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to A.-C.G. A.-C.G. is the Canada Research Chair, Tier 1, in Functional Proteomics.

Back to top
Posted May 10, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Phase I study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B
Natalia Martin Orozco, Noah Vale, Alan Mihic, Talya Amor, Lawrence Reiter, Yuko Arita, Reuben Samson, Queenie Hu, Anne-Claude Gingras, Brad Sorenson, Eric G. Marcusson, Piyush Patel
medRxiv 2022.05.06.22274690; doi: https://doi.org/10.1101/2022.05.06.22274690
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area